These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27569210)

  • 1. SMYD3-Mediated H2A.Z.1 Methylation Promotes Cell Cycle and Cancer Proliferation.
    Tsai CH; Chen YJ; Yu CJ; Tzeng SR; Wu IC; Kuo WH; Lin MC; Chan NL; Wu KJ; Teng SC
    Cancer Res; 2016 Oct; 76(20):6043-6053. PubMed ID: 27569210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
    Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y; Fan Y
    Tumour Biol; 2016 Jun; 37(6):7371-81. PubMed ID: 26676636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANP32e Binds Histone H2A.Z in a Cell Cycle-Dependent Manner and Regulates Its Protein Stability in the Cytoplasm.
    Dijkwel Y; Hart-Smith G; Kurscheid S; Tremethick DJ
    Mol Cell Biol; 2024; 44(2):72-85. PubMed ID: 38482865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription.
    Yang Z; Liu F; Li Z; Liu N; Yao X; Zhou Y; Zhang L; Jiang P; Liu H; Kong L; Lang C; Xu X; Jia J; Nakajima T; Gu W; Zheng L; Zhang Z
    Clin Epigenetics; 2023 May; 15(1):92. PubMed ID: 37237385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.
    Kim H; Heo K; Kim JH; Kim K; Choi J; An W
    J Biol Chem; 2009 Jul; 284(30):19867-77. PubMed ID: 19509295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.
    Vieira FQ; Costa-Pinheiro P; Almeida-Rios D; Graça I; Monteiro-Reis S; Simões-Sousa S; Carneiro I; Sousa EJ; Godinho MI; Baltazar F; Henrique R; Jerónimo C
    Oncotarget; 2015 May; 6(15):13644-57. PubMed ID: 25980436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
    Cock-Rada AM; Medjkane S; Janski N; Yousfi N; Perichon M; Chaussepied M; Chluba J; Langsley G; Weitzman JB
    Cancer Res; 2012 Feb; 72(3):810-20. PubMed ID: 22194464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMYD3 Promotes Homologous Recombination via Regulation of H3K4-mediated Gene Expression.
    Chen YJ; Tsai CH; Wang PY; Teng SC
    Sci Rep; 2017 Jun; 7(1):3842. PubMed ID: 28630472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells.
    Ren TN; Wang JS; He YM; Xu CL; Wang SZ; Xi T
    Med Oncol; 2011 Dec; 28 Suppl 1():S91-8. PubMed ID: 20957523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
    Luo XG; Zhang CL; Zhao WW; Liu ZP; Liu L; Mu A; Guo S; Wang N; Zhou H; Zhang TC
    Cancer Lett; 2014 Mar; 344(1):129-137. PubMed ID: 24189459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone chaperone Anp32e removes H2A.Z from DNA double-strand breaks and promotes nucleosome reorganization and DNA repair.
    Gursoy-Yuzugullu O; Ayrapetov MK; Price BD
    Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7507-12. PubMed ID: 26034280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2A.Z overexpression promotes cellular proliferation of breast cancer cells.
    Svotelis A; Gévry N; Grondin G; Gaudreau L
    Cell Cycle; 2010 Jan; 9(2):364-70. PubMed ID: 20023423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.
    Dai B; Wan W; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
    Oncol Rep; 2015 Nov; 34(5):2722-30. PubMed ID: 26328527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone chaperone Anp32e regulates memory formation, transcription, and dendritic morphology by regulating steady-state H2A.Z binding in neurons.
    Stefanelli G; Makowski CE; Brimble MA; Hall M; Reda A; Creighton SD; Leonetti AM; McLean TAB; Zakaria JM; Baumbach J; Greer CB; Davidoff AM; Walters BJ; Murphy PJ; Zovkic IB
    Cell Rep; 2021 Aug; 36(7):109551. PubMed ID: 34407406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H2A.Z-dependent crosstalk between enhancer and promoter regulates cyclin D1 expression.
    Dalvai M; Bellucci L; Fleury L; Lavigne AC; Moutahir F; Bystricky K
    Oncogene; 2013 Sep; 32(36):4243-51. PubMed ID: 23108396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
    Yoshioka Y; Suzuki T; Matsuo Y; Tsurita G; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
    Cancer Med; 2017 Jul; 6(7):1665-1672. PubMed ID: 28639750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells.
    Kim JM; Kim K; Schmidt T; Punj V; Tucker H; Rice JC; Ulmer TS; An W
    Nucleic Acids Res; 2015 Oct; 43(18):8868-83. PubMed ID: 26350217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53-binding site of the p21 gene in response to doxorubicin.
    Ding J; Yu C; Sui Y; Wang L; Yang Y; Wang F; Yao H; Xing F; Liu H; Li Y; Shah JA; Cai Y; Jin J
    FEBS J; 2018 Sep; 285(17):3270-3285. PubMed ID: 30055111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.